INS and COVID-19: Several studies confirmed the beneficial effect of corticosteroids in patients with COVID-19 [82]; however, an inappropriate dose of corticosteroids in COVID-19 patients can cause various moderate and long-term adverse effects, including increased insulin resistance and cardiovascular risk, bacterial infections, glucose metabolism disturbance, thrombotic complications and allergic reactions.